AI-enabled Digital Animal Replacement Technology as deployable enterprise solution that leverages human MicroPhysiological Platforms

Digital Animal Replacement Technology (DART) marks a major advancement in drug and vaccine development, aligning with New Approach Methodologies (NAMs) and the FDA’s Predictive Toxicology Roadmap while supporting the global 3Rs mandate: Reduce, Refine, and Replace. DART uses human biology and cutting-edge AI to create a continuously evolving simulation infrastructure that enhances safety and efficacy evaluations.

By challenging traditional animal testing methods, DART minimizes animal use and delivers more relevant human-related data, enhancing the predictive power of preclinical testing. This technology not only meets regulatory guidelines but also aligns with societal expectations for animal welfare. Overall, DART enables pharmaceutical companies to better understand their products' impacts, advancing medical research through innovative, human-centered methodologies.